Analyst Ratings For ALNA – Allena Pharmaceuticals (NASDAQ:ALNA)
Today, Roth Capital initiated coverage on ALNA – Allena Pharmaceuticals (NASDAQ:ALNA) with a Buy with a price target of $61.00.
Some recent analyst ratings include
- 4/2/2018-Roth Capital initiated coverage with a Buy rating.
- 3/28/2018-Wedbush Reiterated Rating of Outperform.
- 11/27/2017-Cowen initiated coverage with a Outperform rating.
- 11/27/2017-Jefferies Group initiated coverage with a Buy rating.
- On 11/6/2017 Bessemer Venture Partners Vii, Major Shareholder, bought 36,000 with an average share price of $14.00 per share and the total transaction amounting to $504,000.00.
- On 11/6/2017 James N Topper, Director, bought 500,000 with an average share price of $14.00 per share and the total transaction amounting to $7,000,000.00.
Recent Trading Activity for ALNA – Allena Pharmaceuticals (NASDAQ:ALNA)
Shares of ALNA – Allena Pharmaceuticals closed the previous trading session at with 12.219900131225586 shares trading hands.
